Valley Wealth Managers’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-3,749
Closed -$289K – 350
2023
Q4
$289K Buy
3,749
+688
+22% +$45.3K 0.02% 168
2023
Q3
$208K Buy
3,061
+224
+8% +$17.7K 0.02% 183
2023
Q2
$232K Sell
2,837
-11
-0.4% -$884 0.02% 155
2023
Q1
$211K Buy
2,848
+292
+11% +$22.5K 0.02% 165
2022
Q4
$212K Buy
2,556
+392
+18% +$31.1K 0.02% 161
2022
Q3
$154K Hold
2,164
– – 0.02% 183
2022
Q2
$188K Sell
2,164
-772
-26% -$72.3K 0.02% 189
2022
Q1
$318K Buy
2,936
+300
+11% +$31K 0.03% 153
2021
Q4
$341K Buy
2,636
+312
+13% +$38.2K 0.03% 157
2021
Q3
$282K Buy
2,324
+152
+7% +$18.5K 0.02% 157
2021
Q2
$244K Buy
+2,172
New +$229K 0.02% 174

Other funds holding TECH

Valley Wealth Managers's TECH Position: Q1 2024 in Review

Valley Wealth Managers sold out of Bio-Techne (TECH) in Q1 2024, closing a stake of 3,749 shares — an estimated $289K sold.

Valley Wealth Managers first reported a position in TECH in Q2 2021 and held it in 11 quarters. The position peaked at $341K in Q4 2021. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2024.

  • Valley Wealth Managers reported no remaining Bio-Techne position as of Q1 2024 after selling out during the quarter.
  • Valley Wealth Managers sold 3,749 Bio-Techne shares in Q1 2024, an estimated $289K.
  • Valley Wealth Managers first reported a position in Bio-Techne in Q2 2021 and held it in 11 quarters.
  • Valley Wealth Managers's Bio-Techne position peaked at $341K in Q4 2021.
  • 557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2024.

Based on Valley Wealth Managers's 13F filing for Q1 2024, filed 3 May 2024.